-Katsuto Tamai Researcher Activity Profile

Research Author Detailed Information 

Katsuto Tamai Publication Rate By Year

Katsuto Tamai has published 13 paper(s) in 2007, 4 paper(s) in 2008, for a total of 17 research publications in total.

Katsuto K Tamai Author Information

LAST NAME: tamai

FIRST NAME: katsuto

INITIALS: K

AFFILIATION:

Papers

Katsuto Tamai's Publication Record

1. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Year Published: 2007
Division of Gene Therapy Science, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
2. Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis. Year Published: 2007
Department of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
3. Involvement of gamma-secretase in postnatal angiogenesis. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
4. Involvement of gamma-secretase in postnatal angiogenesis. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
5. Development of tissue-targeting hemagglutinating virus of Japan envelope vector for successful delivery of therapeutic gene to mouse skin. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
6. Development of a transferrin receptor-targeting HVJ-E vector. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
7. Development of tissue-targeting hemagglutinating virus of Japan envelope vector for successful delivery of therapeutic gene to mouse skin. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
8. Development of a transferrin receptor-targeting HVJ-E vector. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
9. Functional modification of Sendai virus by siRNA. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
10. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Year Published: 2008
Division of Gene Therapy Science, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
11. Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis. Year Published: 2007
Department of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
12. Involvement of gamma-secretase in postnatal angiogenesis. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
13. Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vector. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
14. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Year Published: 2008
Division of Gene Therapy Science, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
15. Functional modification of Sendai virus by siRNA. Year Published: 2007
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
16. Cutaneous gene delivery. Year Published: 2008
Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
17. Vitamin D(3) inhibits expression of bullous pemphigoid antigen 1 through post-transcriptional mechanism without new protein synthesis. Year Published: 2008
Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.